Hasil Pencarian

✨ 141 results found - Searched 22088 records in 6ms.
cover

Tesis

Akurasi Immunoscore dan Rasio Netrofil Limfosit Dalam Prediksi Kekambuhan 5 Tahun Pada Pasien Kanker Kolorektal Stadium I-III
2024 | BY Yusak Kristianto - Wifanto Saditya Jeo
  • The accuracy of Immunoscore and Neutrophil Lymphocyte Ratio in Predicting 5 years recurrence of stage I-III colorectal cancer.
  • Nomor Panggil T24302fk
cover

Tesis

Kepatuhan terhadap Timely Completion pada Kanker Serviks Stadium Lokal Lanjut dan Faktor-Faktor yang Berhubungan di RSUPN Dr. Cipto Mangunkusumo pada Tahun 2019
2023 | BY Gatot Purwoto - Rebecca Octavia Fransisca Tobing
  • Compliance Towards Timely Treatment in Locally Advanced Cervical Cancer: A Study of Influential Factors from Indonesia National General Hospital in 2019.
  • Nomor Panggil T23619fk
cover

Tesis

Perbandingan Circulating Tumor Cell Sebelum dan Setelah Kemoterapi Pada Pasien Kanker Payudara Stadium Lokal Lanjut dan Lanjut Serta Faktor Yang Memengaruhinya
2024 | BY Annisa Syafitri - IGN Gunawan Wibisana - Bob Andinata - Ninik Sukartini - Herqutanto
  • Comparison of Circulating Tumor Cells (CTC) Before and After Chemotherapy For Locally Advance or Advance Breast Cancer Patients and Its Influencing Factors.
  • Nomor Panggil T24134fk
cover

Tesis

CD 105 sebagai faktor prognostik pada pasien kanker payudara stadium lanjut.
2016 | BY Dedy Hermansyah - H. Zafiral Azdi Albar - Denni Joko Purwanto - Lenny Sari - Rizky Ifandriani Putri
  • CD 105 as a prognostic factor for late stage breast cancer patients.
  • Nomor Panggil T16164fk
cover

Tesis

Efek Terapi Dignity Versi Bahasa Indonesia terhadap Kualitas Hidup Lansia dengan Kanker Stadium Lanjut di Rumah Sakit Cipto Mangunkusumo
2024 | BY Profitasari Kusumaningrum - Rahajeng Dewantari - Martina Wiwie S. Nasrun
  • Efek Terapi Dignity Versi Bahasa Indonesia terhadap Kualitas Hidup Lansia dengan Kanker Stadium Lanjut di Rumah Sakit Cipto Mangunkusumo.
  • Nomor Panggil T24104fk
cover

Tesis

Status Fungsional, Rasio Limfosit Monosit dan Rasio Trombosit Limfosit sebagai Faktor Prognosis Kesintasan Satu Tahun Pasien Lanjut Usia dengan Kanker Paru Karsinoma Bukan Sel Kecil Stadium IIIB-IV
2024 | BY Ratna Nurhayati - Aulia Rizka - Noorwati Sutandyo - Cleopas Martin Rumende
  • Functional Status, Lymphocyte to Monocyte Ratio and Platelet to Lymphocyte Ratio as a Prognostic Factor of 1-year Survival in Elderly with Non-Small Cell Lung Stage IIIB-IV.
  • Nomor Panggil T24053fk
cover

Tesis

Kadar HIF-1 a Sebagai Prediktor Terapi Radiasi Pada Karsinoma Sel Skuamosa Serviks Stadium IIIB
2023 | BY Yoarva Malano - Fitriyadi Kusuma - Ani Retno Prijanti
  • HIF-1α Levels As Predictors of Radiation Therapy in Stage IIIB Cervical Squamous Cell Carcinoma.
  • Nomor Panggil T23544fk
cover

Tesis

Telaah Hubungan Riwayat Skrining Kanker Serviks Terhadap Temuan Stadium Pasien Kanker Serviks di Rumah Sakit Cipto Mangunkusumo
2023 | BY Desty Putri Kristianingesti - Gatot Purwoto
  • The Relationship between History of Cervical Cancer Screening and Cervical Cancer Stage at Dr. Cipto Mangunkusumo General Hospital.
  • Nomor Panggil T23543fk
cover

Tesis

Hubungan Antara Rasio Limfosit-Monosit, Tumor-Infiltrating Lymphocytes, dan Tumor-Associated Macrophages dengan Progression-Free Survival 3 Tahun Pasien Kanker Nasofaring Stadium Lokal Lanjut
2023 | BY Ni Putu Merlynda Pusvita Dewi - Andhika Rachman - Lisnawati - Sukamto Koesnoe
  • The Association Between Lymphocyte-Monocyte Ratio, TumorInfiltrating Lymphocytes, and Tumor-Associated Macrophages with 3-Year Progression-Free Survival in Advanced Local Stage Nasopharyngeal Cancer Patients.
  • Nomor Panggil T23496fk
cover

Tesis

Hubungan ekspresi protein 16 (p16) dan Ki-67 dengan progressionfree survival 3 tahun pasien kanker nasofaring stadium lokal lanjut pasca kemoradiasi berbasis platinum
2023 | BY Nanda Noor Muhammad - Anna Mira Lubis - Lisnawati - Hamzah Shatri
  • Association of Ki-67 and p16 expression with 3-years Progression-Free Survival of Locally Advanced Nasopharyngeal Carcinoma after Platinum-based Concurrent Chemoradiotherapy.
  • Nomor Panggil T23495fk